Manager, Investor Relations and Corporate Communications

About this role

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.

Overview

The Manager, Investor Relations and Corporate Communications, will help drive high-impact communications across investors, media, employees, and other key stakeholders. Reporting to the Senior Director, Corporate Communications, and partnering closely with the Investor Relations and Corporate Communications team, this role will turn company strategy, milestones, and data into clear, compelling communications that support investor engagement, corporate visibility, and internal alignment.

This is a hands-on, execution-oriented role for a strong communicator who thrives in a fast-moving public company environment. The ideal candidate brings curiosity, financial acumen, strong project management skills, and the ability to move quickly from insight to action while supporting executive communications, investor engagement, and commercial-stage biotechnology operations.

Essential Functions and Responsibilities

• Investor Relations & Corporate Communications

• Create and maintain high-impact investor relations and corporate communications materials, including press releases, earnings scripts, Q&A documents, corporate presentations, FAQs, fact sheets, executive biographies, website content, investor decks, templates, and social media content.

• Drive internal reviews, approvals, and final deliverables on behalf of the IR and corporate communications team.

• Support analyst and institutional investor engagement and help advance investor targeting strategies.

• Monitor metrics and analytics for multi-channel external engagement, media coverage, share of voice, company reputation, market activity, analyst sentiment, peer performance, and consensus estimates, to deliver real-time insights for leadership.

• Translate key milestones, including earnings, financings, clinical updates, and business developments, into timely, consistent communications for employees, investors, media, and other stakeholders.

• Own logistics, timelines, briefing materials, and execution support for events led by the team, including internal town halls, media interviews/roundtables and investor days.

• Support media relations by preparing press materials, tracking coverage, and helping build productive relationships with traditional and social media outlets.

• Manage agencies and vendors to keep projects moving, on budget, and aligned with investor relations and corporate communications priorities.

• Cross-Functional & Operational

• Partner with Finance, Legal, Commercial, R&D, Patient Advocacy, and other teams to deliver accurate, consistent, and compliant communications across filings, disclosures, investor materials, the corporate website, internal meetings, and social media.

• Improve processes, tools, and workflows to increase the speed, organization, and scalability of the investor relations and corporate communications function.

• Lead or support priority investor relations and communications projects as business needs evolve.

• Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.

• Perform miscellaneous duties as assigned.

Required Education, Skills, and Knowledge

• 8+ years of experience in investor relations, external and internal corporate communications, public relations, equity research, investment banking, corporate finance, healthcare communications, or related fields.

• Bachelor’s degree required, preferably in Communications, Public Relations, Journalism, Business, Finance, Marketing, Life Sciences, or a related field.

• Experience within biotechnology, pharmaceutical, healthcare, agency, or public company environments strongly preferred.

• Working knowledge of capital markets, valuation, investor behavior, sell-side research, SEC disclosure requirements, Regulation FD, and public company investor relations practices.

• Strong financial and analytical skills, with the ability to turn clinical, scientific, and financial information into clear investment messaging.

• Excellent writer and communicator with experience developing persuasive scripts, presentations, executive materials, and stakeholder communications.

• Highly organized project manager who can manage multiple priorities, timelines, and stakeholders with speed, accuracy, and attention to detail.

• Strong relationship builder with executive presence, sound judgment, and the ability to influence without authority.

• Advanced proficiency in PowerPoint, Excel, Outlook, OneDrive, and SharePoint; experience with FactSet, Bloomberg, HubSpot, WordPress, or market-monitoring platforms is a plus.

• Professional maturity, discretion, and sound judgment in handling confidential information.

• Proactive self-starter who takes ownership, solves problems, and moves work forward with urgency and curiosity.

Physical Demands and Activities Required

The physical demands described here represent those an employee may encounter while performing the essential functions of this job. Reasonable accommodation may be provided to enable individuals to perform these functions.

• Ability to remain in a stationary position for extended periods

• Ability to move about within an office or remote workspace and exert up to 10 pounds of force occasionally

• Visual acuity sufficient for preparing and analyzing data, viewing computer screens, and extensive reading

• Repetitive motion involving wrists, hands, and/or finge

Similar jobs

• Director, Investor Relations and External Communications — Precisionmedicinegroup · New York, NY, USA
• Director, Investor Relations and External Communications — Precisionaq · New York, NY, USA
• Analyst, Investor Relations and External Communications — Precisionmedicinegroup · New York, NY, USA
• Analyst, Investor Relations and External Communications — Precisionaq · New York, NY, USA
• Senior Analyst, Investor Relations and External Communications — Precisionmedicinegroup · New York, NY, USA
• Senior Analyst, Investor Relations and External Communications — Precisionaq · New York, NY, USA
• Managing Director, Investor Relations — Precisionmedicinegroup · New York, NY, USA
• Managing Director, Investor Relations — Precisionaq · New York, NY, USA